ANNA HARDEN: Open Payments
NPI 1265190979 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $553 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $144 |
| Novo Nordisk Inc | 6 | $123 |
| ABBVIE INC. | 4 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| ViiV Healthcare Company | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: MOUNJARO, Ozempic, JARDIANCE, REXULTI, QULIPTA, Kerendia, VRAYLAR, DOVATO.
Industry payments across NC — which companies pay providers there.
